Guo Boliang, Kaylor-Hughes Catherine, Garland Anne, Nixon Neil, Sweeney Tim, Simpson Sandra, Dalgleish Tim, Ramana Rajini, Yang Min, Morriss Richard
CLAHRC-EM, School of Medicine, University of Nottingham, Nottingham, United Kingdom.
Adult Mental Health Directorate, Nottinghamshire Healthcare Trust, Nottingham, United Kingdom.
J Affect Disord. 2017 Sep;219:1-8. doi: 10.1016/j.jad.2017.05.020. Epub 2017 May 8.
The Patient Health Questionnaire-9 (PHQ-9) is a widely used instrument for measuring levels of depression in patients in clinical practice and academic research; its factor structure has been investigated in various samples, with limited evidence of measurement equivalence/invariance (ME/I) but not in patients with more severe depression of long duration. This study aims to explore the factor structure of the PHQ-9 and the ME/I between treatment groups over time for these patients.
187 secondary care patients with persistent major depressive disorder (PMDD) were recruited to a randomised controlled trial (RCT) with allocation to either a specialist depression team arm or a general mental health arm; their PHQ-9 score was measured at baseline, 3, 6, 9 and 12 months. Exploratory Structural Equational Modelling (ESEM) was performed to examine the factor structure for this specific patient group. ME/I between treatment arm at and across follow-up time were further explored by means of multiple-group ESEM approach using the best-fitted factor structure.
A two-factor structure was evidenced (somatic and affective factor). This two-factor structure had strong factorial invariance between the treatment groups at and across follow up times.
Participants were largely white British in a RCT with 40% attrition potentially limiting the study's generalisability. Not all two-factor modelling criteria were met at every time-point.
PHQ-9 has a two-factor structure for PMDD patients, with strong measurement invariance between treatment groups at and across follow-up time, demonstrating its validity for RCTs and prospective longitudinal studies in chronic moderate to severe depression.
患者健康问卷-9(PHQ-9)是临床实践和学术研究中广泛用于测量患者抑郁水平的工具;其因子结构已在各种样本中进行了研究,测量等效性/不变性(ME/I)的证据有限,且未在患有更严重的长期抑郁症患者中进行研究。本研究旨在探讨PHQ-9的因子结构以及这些患者治疗组之间随时间的ME/I。
187名患有持续性重度抑郁症(PMDD)的二级护理患者被招募到一项随机对照试验(RCT)中,随机分配到专科抑郁症治疗组或一般心理健康治疗组;在基线、3个月、6个月、9个月和12个月时测量他们的PHQ-9得分。采用探索性结构方程模型(ESEM)来检验该特定患者群体的因子结构。使用最佳拟合因子结构,通过多组ESEM方法进一步探讨治疗组在随访时间点及随访期间的ME/I。
证实了一个双因子结构(躯体因子和情感因子)。该双因子结构在治疗组之间的随访时间点及随访期间具有很强的因子不变性。
在一项RCT中,参与者大多为英国白人,40%的失访率可能限制了研究的普遍性。并非在每个时间点都满足所有双因子建模标准。
对于PMDD患者,PHQ-9具有双因子结构,治疗组之间在随访时间点及随访期间具有很强的测量不变性,证明了其在慢性中度至重度抑郁症的RCT和前瞻性纵向研究中的有效性。